Completed OBSERVATIONAL NCT03650816

Cerebrovascular Reactivity in Alzheimer's Disease (VARAD-ET)

Evaluation of Cerebrovascular Reactivity in Alzheimer's Disease Patients : A Pilot Clinical Study

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Alzheimer Disease Subjective Cognitive Impairment

Interventions Biospecimen collection Doppler ultrasonography

Updated 10 times since 2018 Last updated: Jun 21, 2024 Started: Oct 22, 2019 Primary completion: Feb 15, 2023 Completion: Feb 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03650816, this observational or N/A phase trial focuses on Alzheimer Disease and Subjective Cognitive Impairment and remains completed. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 10 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed

Status: Unknown Status → Completed
Nov 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Nov 2021 — Nov 2023 [monthly]

Recruiting
Jan 2021 — Nov 2021 [monthly]

Recruiting

▶ Show 5 earlier versions

May 2020 — Jan 2021 [monthly]

Recruiting
Feb 2020 — May 2020 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Sep 2019 — Feb 2020 [monthly]

Not Yet Recruiting
Feb 2019 — Sep 2019 [monthly]

Not Yet Recruiting
Sep 2018 — Feb 2019 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris
Fondation Plan Alzheimer
Naturalia & Biologia

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France